Securities Times e Company Newswolfwinnernodepositbonus, Jincheng Pharmaceutical (300233) announced on the evening of May 14 that its wholly-owned subsidiary Jincheng Taier received a issuance from the State Food and Drug Administration.wolfwinnernodepositbonusThe approval notice for the marketing application of lornoxicam indicates that the API can be produced and sold in the domestic market. Lornoxicam is a non-steroidal anti-inflammatory drug with strong analgesic and antipyretic effects.